BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Satta N, Frias MA, Vuilleumier N, Pagano S. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases? Curr Pharm Des 2019;25:3128-46. [PMID: 31470782 DOI: 10.2174/1381612825666190830164917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Nessler K, Grzybczak R, Nessler M, Zalewski J, Gajos G, Windak A. Associations between myeloperoxidase and paraoxonase-1 and type 2 diabetes in patients with ischemic heart disease. BMC Cardiovasc Disord 2022;22:521. [PMID: 36463116 DOI: 10.1186/s12872-022-02928-8] [Reference Citation Analysis]
2 Vuilleumier N, Pagano S, Ludewig B, Schmiedeberg K, Haller C, von Kempis J, Rubbert-Roth A. Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1? Eur J Clin Invest 2022;52:e13713. [PMID: 34841527 DOI: 10.1111/eci.13713] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Vuilleumier N, Antiochos P, Marques-Vidal P, Pagano S, Virzi J, Satta N, Hartley O, Gaertner H, Brandt KJ, Burger F, Montecucco F, Waeber G, Mach F, Vollenweider P. Prognostic and therapeutic considerations of antibodies against c-ter apolipoprotein A-1 in the general population. Clin Transl Immunology 2020;9:e1220. [PMID: 33343896 DOI: 10.1002/cti2.1220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Banks WA. A Spectrum of Topics for 2019: Advances in Neuroinflammation, Oxidative Stress, Obesity, Diabetes Mellitus, Cardiovascular Disease, Autism, Exosomes, and Central Nervous System Diseases. Curr Pharm Des 2020;26:1-5. [PMID: 32122292 DOI: 10.2174/138161282601200225102049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Vuilleumier N. Anti‐Apolipoprotein A‐I in Systemic Lupus Erythematosus: Comment on the Article by Kim et al. Arthritis Rheumatol 2020;72:1233-1234. [DOI: 10.1002/art.41235] [Reference Citation Analysis]
6 Yu M, Kim SY, Morin EE, Schwendeman A. Reply. Arthritis Rheumatol 2020;72:1234-6. [PMID: 32103638 DOI: 10.1002/art.41237] [Reference Citation Analysis]
7 Carbone F, Montecucco F. Inflammatory Targets for Preventing Atherothrombotic Events: An Update. Curr Pharm Des 2019;25:3097. [PMID: 31722653 DOI: 10.2174/138161282529191007154601] [Reference Citation Analysis]